|
|
|
|
|
1.
1378 Accesses
|
MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7
Seok-Jun Kim, Ji-Young Shin, Kang-Duck Lee, Young-Ki Bae, Ki Sung, Seok Nam, Kyung-Hee Chun Breast Cancer Research 2012, 14:R14 (18 January 2012)
Abstract | Provisional PDF
| PubMed
|
Editor’s summary
MicroRNA let-7a binds directly to the 3'UTR of C-C chemokine receptor type 7 (CCR7), blocking its protein expression and suppressing migration and invasion of breast cancer cells.
|
|
|
2.
1305 Accesses
|
Long-term prognosis of breast cancer detected by mammography screening or other methods
Tiina Lehtimäki, Mikael Lundin, Nina Linder, Harri Sihto, Kaija Holli, Taina Turpeenniemi-Hujanen, Vesa Kataja, Jorma Isola, Heikki Joensuu, Johan Lundin Breast Cancer Research 2011, 13:R134 (28 December 2011)
Abstract | Full text | PDF | PubMed |
|
Editor’s summary
Patients with breast cancer detected in mammography screening have a more favorable prognosis than those diagnosed outside a screening program and this should be taken into account in order to avoid over-treatment of screen-detected patients.
|
|
|
3.
1234 Accesses
|
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome
Grazia Arpino, Valerie J Bardou, Gary M Clark, Richard M Elledge Breast Cancer Res 2004, 6:R149-R156 (17 February 2004)
Abstract | Full text | PDF | Cited on BioMed Central
|
|
|
4.
1203 Accesses
|
Do fatty breasts increase or decrease breast cancer risk?
John A Shepherd, Karla Kerlikowske Breast Cancer Research 2012, 14:102 (25 January 2012)
Abstract | Full text | PDF | PubMed
|
|
|
5.
1129 Accesses
|
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
Sabine Kasimir-Bauer, Oliver Hoffmann, Diethelm Wallwiener, Rainer Kimmig, Tanja Fehm Breast Cancer Research 2012, 14:R15 (20 January 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
6.
1011 Accesses
|
Epithelial-mesenchymal transition, cancer stem cells and treatment resistance
Bhuvanesh Dave, Vivek Mittal, Nicholas M Tan, Jenny C Chang Breast Cancer Research 2011, 14:202 (19 January 2012)
Abstract | Full text | PDF
|
|
|
7.
980 Accesses
|
Mouse models of breast cancer metastasis
Anna Fantozzi, Gerhard Christofori Breast Cancer Research 2006, 8:212 (26 July 2006)
Abstract | Full text | PDF | PubMed
|
|
|
8.
913 Accesses
|
Breast asymmetry and predisposition to breast cancer
Diane Scutt, Gillian A Lancaster, John T Manning Breast Cancer Research 2006, 8:R14 (20 March 2006)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Breast asymmetry could be a predictor of breast cancer, with the relative risk of developing cancer rising with increases in breast volume asymmetry.
|
|
|
9.
878 Accesses
|
Molecular profiling of patient-derived breast cancer xenografts
Fabien Reyal, Charlotte Guyader, Charles Decraene, Carlo Lucchesi, Nathalie Auger, Franck Assayag, Ludmilla De Plater, David Gentien, Marie-France Poupon, Paul Cottu, Patricia DeCremoux, Pierre Gestraud, Anne Vincent-Salomon, Jean-Jacques Fontaine, Sergio Roman-Roman, Olivier Delattre, Didier Decaudin, Elisabetta Marangoni Breast Cancer Research 2012, 14:R11 (16 January 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
10.
846 Accesses
|
Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer
Luciana P Schwab, Danielle L Peacock, Debeshi Majumdar, Jesse F Ingels, Laura C Jensen, Keisha D Smith, Richard C Cushing, Tiffany N Seagroves Breast Cancer Research 2012, 14:R6 (7 January 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
11.
831 Accesses
|
Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers - role of estrogen receptor and HER2 reactivation
Yen-Chao Wang, Gladys Morrison, Ryan Gillihan, Jun Guo, Robin M Ward, Xiaoyong Fu, Maria F Botero, Nuala A Healy, Susan G Hilsenbeck, Gail L Phillips, Gary C Chamness, Mothaffar F Rimawi, C Kent Osborne, Rachel Schiff Breast Cancer Research 2011, 13:R121 (28 November 2011)
Abstract | Provisional PDF
| PubMed
|
Editor’s summary
Combined lapatinib and trastuzumab therapy may improve outcomes in patients with human epidermal growth factor 2 (HER2)-positive breast cancer; adding estrogen receptor inhibition may be optimal in some patients.
|
|
|
12.
807 Accesses
|
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat, Joel S Parker, Olga Karginova, Cheng Fan, Chad Livasy, Jason I Herschkowitz, Xiaping He, Charles M Perou Breast Cancer Research 2010, 12:R68 (2 September 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
13.
807 Accesses
|
The microenvironment in breast cancer progression: biology and implications for treatment
Andrew E Place, Sung Jin Huh, Kornelia Polyak Breast Cancer Research 2011, 13:227 (1 November 2011)
Abstract | Full text | PDF | PubMed
|
|
|
14.
807 Accesses
|
Epigenetics in breast cancer: what's new?
Yi Huang, Shweta Nayak, Rachel Jankowitz, Nancy E Davidson, Steffi Oesterreich Breast Cancer Research 2011, 13:225 (1 November 2011)
Abstract | Full text | PDF | PubMed
|
|
|
15.
770 Accesses
|
Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer
Todd W Miller, Brent N Rexer, Joan T Garrett, Carlos L Arteaga Breast Cancer Research 2011, 13:224 (1 November 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
16.
735 Accesses
|
Lack of EGFR activating mutations in European patients with triple negative breast cancer could emphasize geographic and ethnic variations in breast cancer mutation profiles
William Jacot, Evelyne Lopez-Crapez, Simon Thezenas, Romain Senal, Frederic Fina, Frederic Bibeau, Gilles Romieu, Pierre-Jean Lamy Breast Cancer Research 2011, 13:R133 (22 December 2011)
Abstract | Provisional PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
Potential geographic and ethnic variations in the prevalence of EGFR mutations in triple negative breast cancer have implications for clinical trial design for anti-estrogen growth factor receptor (EGFR) therapies.
|
|
|
17.
735 Accesses
|
Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers
Desheng Weng, Jeffrey H Penzner, Baizheng Song, Shigeo Koido, Stuart K. Calderwood, Jianlin Gong Breast Cancer Research 2012, 14:R18 (25 January 2012)
Abstract | Provisional PDF
| PubMed
|
|
|
18.
713 Accesses
|
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
H Raza Ali, Sarah-Jane Dawson, Fiona M Blows, Elena Provenzano, Paul D Pharoah, Carlos Caldas Breast Cancer Research 2011, 13:R118 (23 November 2011)
Abstract | Full text | PDF | PubMed
|
|
|
19.
689 Accesses
|
Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue
Mariëtte Lokate, Petra HM Peeters, Linda M Peelen, Gerco Haars, Wouter B Veldhuis, Carla H van Gils Breast Cancer Research 2011, 13:R103 (26 October 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
When studying the relationship between breast dense area and breast cancer risk, adjustments for non-dense tissue may give more valid results than adjustment for BMI.
|
|
|
20.
687 Accesses
|
Luminal-B breast cancer and novel therapeutic targets
Ben Tran, Philippe L Bedard Breast Cancer Research 2011, 13:221 (30 November 2011)
Abstract | Full text | PDF | PubMed
|
|
|
21.
677 Accesses
|
Mammographic density and breast cancer risk: current understanding and future prospects
Norman F Boyd, Lisa J Martin, Martin J Yaffe, Salomon Minkin Breast Cancer Research 2011, 13:223 (1 November 2011)
Abstract | Full text | PDF | PubMed
|
|
|
22.
663 Accesses
|
The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis
Oriana E Hawkins, Ann Richmond Breast Cancer Research 2012, 14:103 (26 January 2012)
Abstract | Full text | PDF | PubMed
|
|
|
23.
641 Accesses
|
Next-generation sequencing
Jorge S Reis-Filho Breast Cancer Research 2009, 11(Suppl 3):S12 (18 December 2009)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
24.
638 Accesses
|
Coffee consumption modifies risk of estrogen-receptor negative breast cancer
Jingmei Li, Petra Seibold, Jenny Chang-Claude, Dieter Flesch-Janys, Jianjun Liu, Kamila Czene, Keith Humphreys, Per Hall Breast Cancer Research 2011, 13:R49 (14 May 2011)
Abstract | Full text | PDF | PubMed | F1000 Biology
|
Editor’s summary
A Swedish study finds that a high daily intake of coffee is associated with a statistically significant decrease in estrogen receptor-negative breast cancer among postmenopausal women.
|
|
|
25.
629 Accesses
|
Breast cancer cell lines: friend or foe?
Sarah E Burdall, Andrew M Hanby, Mark RJ Lansdown, Valerie Speirs Breast Cancer Res 2003, 5:89-95 (3 February 2003)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|